{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:58Z","timestamp":1786119598344,"version":"build-2736575974"},"reference-count":275,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/dbp.0b013e3181ee3833","type":"journal-article","created":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T08:16:22Z","timestamp":1283415382000},"page":"564-581","source":"Crossref","is-referenced-by-count":45,"title":["Emerging Pharmacotherapies for Neurodevelopmental Disorders"],"prefix":"10.1097","volume":"31","author":[{"given":"Daniel Z.","family":"Wetmore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig C.","family":"Garner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210129","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.amjmed.2004.03.042","article-title":"Adult phenylketonuria.","volume":"117","author":"Hanley","year":"2004","journal-title":"Am J Med"},{"key":"R2-9-20210129","first-page":"225","article-title":"Developmental aspects of lissencephaly and the lissencephaly syndromes.","volume":"23","author":"Dobyns","year":"1987","journal-title":"Birth Defects Orig Artic Ser"},{"key":"R3-9-20210129","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tins.2007.07.005","article-title":"Over-inhibition: a model for developmental intellectual disability.","volume":"30","author":"Fernandez","year":"2007","journal-title":"Trends Neurosci"},{"key":"R4-9-20210129","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1126\/science.285.5435.1870","article-title":"Long-term potentiation\u2014a decade of progress?","volume":"285","author":"Malenka","year":"1999","journal-title":"Science"},{"key":"R5-9-20210129","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.neuron.2008.12.007","article-title":"Reversing neurodevelopmental disorders in adults.","volume":"60","author":"Ehninger","year":"2008","journal-title":"Neuron"},{"key":"R6-9-20210129","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s11689-009-9018-7","article-title":"Adult reversal of cognitive phenotypes in neurodevelopmental disorders.","volume":"1","author":"Silva","year":"2009","journal-title":"J Neurodev Disord"},{"key":"R7-9-20210129","first-page":"81","article-title":"Scl\u00e9rose tub\u00e9reuse des circonvolutions c\u00e9r\u00e9brales.","volume":"1","author":"Bourneville","year":"1880","journal-title":"Arch Int Neurol"},{"key":"R9-9-20210129","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaad.2007.05.004","article-title":"Tuberous sclerosis complex: advances in diagnosis, genetics, and management.","volume":"57","author":"Schwartz","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R10-9-20210129","first-page":"259","article-title":"Observations on an ethnic classification of idiots.","volume":"3","author":"Down","year":"1866","journal-title":"Lond Hosp Rep"},{"key":"R11-9-20210129","first-page":"256","article-title":"[Mongolism; a chromosomal disease (trisomy).]","volume":"143","author":"Lejeune","year":"1959","journal-title":"Bull Acad Natl Med"},{"key":"R12-9-20210129","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/physiolgenomics.00067.2002","article-title":"Of mice and models: improved animal models for biomedical research.","volume":"11","author":"Bockamp","year":"2002","journal-title":"Physiol Genomics"},{"key":"R13-9-20210129","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ajog.2004.06.050","article-title":"Down syndrome births in the United States from 1989 to 2001.","volume":"191","author":"Egan","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R14-9-20210129","doi-asserted-by":"crossref","first-page":"b3794","DOI":"10.1136\/bmj.b3794","article-title":"Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register.","volume":"339","author":"Morris","year":"2009","journal-title":"BMJ"},{"key":"R15-9-20210129","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(03)12987-X","article-title":"Down's syndrome.","volume":"361","author":"Roizen","year":"2003","journal-title":"Lancet"},{"key":"R16-9-20210129","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/mrdd.20156","article-title":"Down syndrome: cognitive phenotype.","volume":"13","author":"Silverman","year":"2007","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"R17-9-20210129","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1034\/j.1601-183X.2003.00026.x","article-title":"Down's syndrome: a genetic disorder in biobehavioral perspective.","volume":"2","author":"Nadel","year":"2003","journal-title":"Genes Brain Behav"},{"key":"R18-9-20210129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/1467-8624.00522","article-title":"The neuropsychology of Down syndrome: evidence for hippocampal dysfunction.","volume":"74","author":"Pennington","year":"2003","journal-title":"Child Dev"},{"key":"R19-9-20210129","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(02)08092-3","article-title":"Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study.","volume":"359","author":"Yang","year":"2002","journal-title":"Lancet"},{"key":"R20-9-20210129","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nrg1448","article-title":"Chromosome 21 and down syndrome: from genomics to pathophysiology.","volume":"5","author":"Antonarakis","year":"2004","journal-title":"Nat Rev Genet"},{"key":"R21-9-20210129","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gene.2005.07.019","article-title":"Human chromosome 21\/Down syndrome gene function and pathway database.","volume":"364","author":"Nikolaienko","year":"2005","journal-title":"Gene"},{"key":"R22-9-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00439-009-0696-8","article-title":"Molecular genetic analysis of Down syndrome.","volume":"126","author":"Patterson","year":"2009","journal-title":"Hum Genet"},{"key":"R23-9-20210129","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1101\/gr.2090904","article-title":"Gene expression from the aneuploid chromosome in a trisomy mouse model of Down syndrome.","volume":"14","author":"Lyle","year":"2004","journal-title":"Genome Res"},{"key":"R24-9-20210129","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.tips.2009.10.010","article-title":"Molecular basis of pharmacotherapies for cognition in Down syndrome.","volume":"31","author":"Gardiner","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"R25-9-20210129","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/mrdd.20164","article-title":"Using mouse models to explore genotype-phenotype relationship in Down syndrome.","volume":"13","author":"Salehi","year":"2007","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"R26-9-20210129","first-page":"263","article-title":"Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome.","volume":"360","author":"Davisson","year":"1990","journal-title":"Prog Clin Biol Res"},{"key":"R27-9-20210129","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1523\/JNEUROSCI.1547-09.2009","article-title":"The \u201cDown syndrome critical region\u201d is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome.","volume":"29","author":"Belichenko","year":"2009","journal-title":"J Neurosci"},{"key":"R28-9-20210129","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/hmg\/ddm022","article-title":"Trisomy for the Down syndrome \u2018critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.","volume":"16","author":"Olson","year":"2007","journal-title":"Hum Mol Genet"},{"key":"R29-9-20210129","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0006-8993(00)01984-3","article-title":"Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice.","volume":"858","author":"Kurt","year":"2000","journal-title":"Brain Res"},{"key":"R30-9-20210129","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/cne.21895","article-title":"Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of Down syndrome.","volume":"512","author":"Belichenko","year":"2009","journal-title":"J Comp Neurol"},{"key":"R31-9-20210129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cne.20337","article-title":"Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome.","volume":"480","author":"Belichenko","year":"2004","journal-title":"J Comp Neurol"},{"key":"R32-9-20210129","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/cne.21433","article-title":"Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships.","volume":"504","author":"Belichenko","year":"2007","journal-title":"J Comp Neurol"},{"key":"R33-9-20210129","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/sj.npp.1301535","article-title":"Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test.","volume":"33","author":"Costa","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"R34-9-20210129","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neulet.2005.03.031","article-title":"Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome.","volume":"382","author":"Costa","year":"2005","journal-title":"Neurosci Lett"},{"key":"R35-9-20210129","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nn1860","article-title":"Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome.","volume":"10","author":"Fernandez","year":"2007","journal-title":"Nat Neurosci"},{"key":"R36-9-20210129","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1523\/JNEUROSCI.1766-04.2004","article-title":"Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome.","volume":"24","author":"Kleschevnikov","year":"2004","journal-title":"J Neurosci"},{"key":"R37-9-20210129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neulet.2007.12.039","article-title":"Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome.","volume":"433","author":"Rueda","year":"2008","journal-title":"Neurosci Lett"},{"key":"R38-9-20210129","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0028-3908(99)00083-0","article-title":"Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome.","volume":"38","author":"Siarey","year":"1999","journal-title":"Neuropharmacology"},{"key":"R39-9-20210129","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.1471-4159.2006.03971.x","article-title":"Altered signaling pathways underlying abnormal hippocampal synaptic plasticity in the Ts65Dn mouse model of Down syndrome.","volume":"98","author":"Siarey","year":"2006","journal-title":"J Neurochem"},{"key":"R40-9-20210129","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1113\/jphysiol.1973.sp010273","article-title":"Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path.","volume":"232","author":"Bliss","year":"1973","journal-title":"J Physiol"},{"key":"R41-9-20210129","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1528-1157.1972.tb04401.x","article-title":"A permanent change in convulsive threshold in normal and brain-damaged rats with repeated small doses of pentylenetetrazol.","volume":"13","author":"Mason","year":"1972","journal-title":"Epilepsia"},{"key":"R42-9-20210129","first-page":"721","article-title":"Treatment of schizophrenia by Meduna's method.","volume":"38","author":"Kruger","year":"1936","journal-title":"Psych Neurol Wchnschr"},{"key":"R43-9-20210129","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1001\/archpsyc.1971.01750150092014","article-title":"A controlled study of drugs in long-term geriatric psychiatric patients.","volume":"25","author":"Lu","year":"1971","journal-title":"Arch Gen Psych"},{"key":"R44-9-20210129","first-page":"231","article-title":"Pentylenetetrazol (metrazol) in mental deficiency.","volume":"94","author":"Berman","year":"1957","journal-title":"AMA J Dis Child"},{"key":"R45-9-20210129","article-title":"Alleviation of Cognitive Deficits in Ts65Dn Mice Modeling Down Syndrome by Pharmacological Inhibition of GABAergic Transmission. Program No. 829.16. 2009 Neuroscience Meeting Planner.","author":"Delatour","year":"2009"},{"key":"R46-9-20210129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pharmthera.2009.09.001","article-title":"Preclinical and clinical pharmacology of the GABA(A) receptor alpha5 subtype-selective inverse agonist alpha5IA.","volume":"125","author":"Atack","year":"2010","journal-title":"Pharmacol Ther"},{"key":"R47-9-20210129","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/cne.20844","article-title":"Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome.","volume":"494","author":"Harashima","year":"2006","journal-title":"J Comp Neurol"},{"key":"R48-9-20210129","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1152\/jn.00626.2006","article-title":"Ts65Dn, a mouse model of Down syndrome, exhibits increased GABAB-induced potassium current.","volume":"97","author":"Best","year":"2007","journal-title":"J Neurophysiol"},{"key":"R49-9-20210129","article-title":"Antagonists of the GABAB receptors enhance LTP and reduce pro-epileptiform activity in Ts65Dn mouse model of Down syndrome. Program No. 348.4. 2008 Neuroscience Meeting Planner.","author":"Kleschevnikov","year":"2008"},{"key":"R50-9-20210129","doi-asserted-by":"crossref","first-page":"10439","DOI":"10.1073\/pnas.181219298","article-title":"Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion.","volume":"98","author":"Cooper","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R51-9-20210129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2006.05.022","article-title":"Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.","volume":"51","author":"Salehi","year":"2006","journal-title":"Neuron"},{"key":"R52-9-20210129","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1006\/exnr.1999.7289","article-title":"Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome.","volume":"161","author":"Granholm","year":"2000","journal-title":"Exp Neurol"},{"key":"R53-9-20210129","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.expneurol.2008.11.021","article-title":"Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model.","volume":"216","author":"Lockrow","year":"2009","journal-title":"Exp Neurol"},{"key":"R54-9-20210129","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archneur.1989.00520440031017","article-title":"A prospective study of Alzheimer disease in Down syndrome.","volume":"46","author":"Lai","year":"1989","journal-title":"Arch Neurol"},{"key":"R55-9-20210129","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1212\/WNL.35.7.957","article-title":"Alzheimer's disease in Down's syndrome: clinicopathologic studies.","volume":"35","author":"Wisniewski","year":"1985","journal-title":"Neurology"},{"key":"R56-9-20210129","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/ajmg.a.32953","article-title":"The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome.","volume":"149A","author":"Kishnani","year":"2009","journal-title":"Am J Med Genet A"},{"key":"R57-9-20210129","article-title":"Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome.","author":"Lockrow","year":"2010","journal-title":"Behav Brain Res"},{"key":"R58-9-20210129","doi-asserted-by":"crossref","first-page":"7ra17","DOI":"10.1126\/scitranslmed.3000258","article-title":"Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome.","volume":"1","author":"Salehi","year":"2009","journal-title":"Sci Transl Med"},{"key":"R59-9-20210129","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.expneurol.2006.02.005","article-title":"Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome.","volume":"200","author":"Clark","year":"2006","journal-title":"Exp Neurol"},{"key":"R60-9-20210129","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants.","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"R61-9-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/hmg\/9.2.195","article-title":"Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse.","volume":"9","author":"Baxter","year":"2000","journal-title":"Hum Mol Genet"},{"key":"R62-9-20210129","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1073\/pnas.0510750103","article-title":"Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome mice.","volume":"103","author":"Roper","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R63-9-20210129","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.mod.2008.11.002","article-title":"A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog.","volume":"126","author":"Roper","year":"2009","journal-title":"Mech Dev"},{"key":"R64-9-20210129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/ejpn.2002.0596","article-title":"Systematic review of the effect of therapeutic dietary supplements and drugs on cognitive function in subjects with Down syndrome.","volume":"6","author":"Salman","year":"2002","journal-title":"Eur J Paediatr Neurol"},{"key":"R65-9-20210129","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bbr.2007.11.020","article-title":"Effects of chronic administration of SGS-111 during adulthood and during the pre- and post-natal periods on the cognitive deficits of Ts65Dn mice, a model of Down syndrome.","volume":"188","author":"Rueda","year":"2008","journal-title":"Behav Brain Res"},{"key":"R66-9-20210129","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/jmg.2008.059055","article-title":"The fragile X prevalence paradox.","volume":"45","author":"Hagerman","year":"2008","journal-title":"J Med Genet"},{"key":"R67-9-20210129","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G","article-title":"Prevalence of fragile X syndrome.","volume":"64","author":"Turner","year":"1996","journal-title":"Am J Med Genet"},{"key":"R68-9-20210129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/mrdd.20003","article-title":"Attention and language in fragile X.","volume":"10","author":"Cornish","year":"2004","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"R69-9-20210129","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1542\/peds.2008-0317","article-title":"Advances in the treatment of fragile X syndrome.","volume":"123","author":"Hagerman","year":"2009","journal-title":"Pediatrics"},{"key":"R70-9-20210129","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2788.2008.01056.x","article-title":"The fragile X continuum: new advances and perspectives.","volume":"52","author":"Cornish","year":"2008","journal-title":"J Intellect Disabil Res"},{"key":"R71-9-20210129","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","article-title":"Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.","volume":"65","author":"Verkerk","year":"1991","journal-title":"Cell"},{"key":"R72-9-20210129","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1126\/science.2006411","article-title":"Isolation of sequences that span the fragile X and identification of a fragile X-related CpG island.","volume":"251","author":"Heitz","year":"1991","journal-title":"Science"},{"key":"R73-9-20210129","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/1.6.397","article-title":"DNA methylation represses FMR-1 transcription in fragile X syndrome.","volume":"1","author":"Sutcliffe","year":"1992","journal-title":"Hum Mol Genet"},{"key":"R74-9-20210129","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0968-0004(03)00033-1","article-title":"New insights into fragile X syndrome: from molecules to neurobehaviors.","volume":"28","author":"Jin","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"R75-9-20210129","doi-asserted-by":"crossref","first-page":"15201","DOI":"10.1073\/pnas.0404995101","article-title":"The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development.","volume":"101","author":"Lu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R76-9-20210129","doi-asserted-by":"crossref","first-page":"14374","DOI":"10.1073\/pnas.2336265100","article-title":"The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95.","volume":"100","author":"Todd","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R77-9-20210129","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nn1893","article-title":"A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability.","volume":"10","author":"Zalfa","year":"2007","journal-title":"Nat Neurosci"},{"key":"R78-9-20210129","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ajmg.1320410306","article-title":"Analysis of neocortex in three males with the fragile X syndrome.","volume":"41","author":"Hinton","year":"1991","journal-title":"Am J Med Genet"},{"key":"R79-9-20210129","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1073\/pnas.94.10.5401","article-title":"Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits.","volume":"94","author":"Comery","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R80-9-20210129","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ajmg.a.30709","article-title":"Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome.","volume":"135","author":"Galvez","year":"2005","journal-title":"Am J Med Genet A"},{"key":"R81-9-20210129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0006-8993(03)02363-1","article-title":"Somatosensory cortical barrel dendritic abnormalities in a mouse model of the fragile X mental retardation syndrome.","volume":"971","author":"Galvez","year":"2003","journal-title":"Brain Res"},{"key":"R82-9-20210129","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neuron.2005.07.005","article-title":"Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome.","volume":"47","author":"Koekkoek","year":"2005","journal-title":"Neuron"},{"key":"R83-9-20210129","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ajmg.b.30183","article-title":"Dendritic spine abnormalities in the occipital cortex of C57BL\/6 Fmr1 knockout mice.","volume":"136B","author":"McKinney","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R84-9-20210129","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1523\/JNEUROSCI.21-14-05139.2001","article-title":"Abnormal development of dendritic spines in FMR1 knock-out mice.","volume":"21","author":"Nimchinsky","year":"2001","journal-title":"J Neurosci"},{"key":"R85-9-20210129","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0896-6273(03)00533-6","article-title":"RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila.","volume":"39","author":"Jin","year":"2003","journal-title":"Neuron"},{"key":"R86-9-20210129","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0896-6273(02)00731-6","article-title":"Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brain.","volume":"34","author":"Morales","year":"2002","journal-title":"Neuron"},{"key":"R87-9-20210129","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1093\/hmg\/ddl422","article-title":"Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and fragile X syndrome.","volume":"15","author":"Tucker","year":"2006","journal-title":"Hum Mol Genet"},{"key":"R88-9-20210129","first-page":"23","article-title":"Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.","volume":"78","year":"1994","journal-title":"Cell"},{"key":"R89-9-20210129","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/dev.20308","article-title":"A mouse model of fragile X syndrome exhibits heightened arousal and\/or emotion following errors or reversal of contingencies.","volume":"50","author":"Moon","year":"2008","journal-title":"Dev Psychobiol"},{"key":"R90-9-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0306-4522(99)00285-7","article-title":"Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function.","volume":"94","author":"Paradee","year":"1999","journal-title":"Neuroscience"},{"key":"R91-9-20210129","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/hmg\/9.8.1145","article-title":"(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features.","volume":"9","author":"Peier","year":"2000","journal-title":"Hum Mol Genet"},{"key":"R92-9-20210129","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1601-183X.2004.00087.x","article-title":"A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse.","volume":"3","author":"Yan","year":"2004","journal-title":"Genes Brain Behav"},{"key":"R93-9-20210129","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0306-4522(01)00036-7","article-title":"Fragile X mice develop sensory hyperreactivity to auditory stimuli.","volume":"103","author":"Chen","year":"2001","journal-title":"Neuroscience"},{"key":"R94-9-20210129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2009.02.066","article-title":"Dissociation of social and nonsocial anxiety in a mouse model of fragile X syndrome.","volume":"454","author":"Liu","year":"2009","journal-title":"Neurosci Lett"},{"key":"R95-9-20210129","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1037\/0735-7044.122.2.293","article-title":"Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome.","volume":"122","author":"McNaughton","year":"2008","journal-title":"Behav Neurosci"},{"key":"R96-9-20210129","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.expneurol.2006.08.007","article-title":"Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes.","volume":"203","author":"Musumeci","year":"2007","journal-title":"Exp Neurol"},{"key":"R97-9-20210129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2174\/1566524013363492","article-title":"Restoring the phenotype of fragile X syndrome: insight from the mouse model.","volume":"1","author":"Gantois","year":"2001","journal-title":"Curr Mol Med"},{"key":"R98-9-20210129","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","article-title":"The mGluR theory of fragile X mental retardation.","volume":"27","author":"Bear","year":"2004","journal-title":"Trends Neurosci"},{"key":"R99-9-20210129","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.tins.2007.06.003","article-title":"The GABAA receptor: a novel target for treatment of fragile X?","volume":"30","author":"D'Hulst","year":"2007","journal-title":"Trends Neurosci"},{"key":"R100-9-20210129","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1073\/pnas.122205699","article-title":"Altered synaptic plasticity in a mouse model of fragile X mental retardation.","volume":"99","author":"Huber","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R101-9-20210129","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.288.5469.1254","article-title":"Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression.","volume":"288","author":"Huber","year":"2000","journal-title":"Science"},{"key":"R102-9-20210129","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1523\/JNEUROSCI.1777-05.2005","article-title":"Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model.","volume":"25","author":"Chuang","year":"2005","journal-title":"J Neurosci"},{"key":"R103-9-20210129","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/cercor\/bhn163","article-title":"Limbic epileptogenesis in a mouse model of fragile X syndrome.","volume":"19","author":"Qiu","year":"2009","journal-title":"Cereb Cortex"},{"key":"R104-9-20210129","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neuron.2007.12.001","article-title":"Correction of fragile X syndrome in mice.","volume":"56","author":"D\u00f6len","year":"2007","journal-title":"Neuron"},{"key":"R105-9-20210129","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.neuron.2005.01.038","article-title":"Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome.","volume":"45","author":"McBride","year":"2005","journal-title":"Neuron"},{"key":"R106-9-20210129","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nbd.2008.04.002","article-title":"Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice.","volume":"31","author":"de Vrij","year":"2008","journal-title":"Neurobiol Dis"},{"key":"R107-9-20210129","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.neuropharm.2005.06.004","article-title":"Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.","volume":"49","author":"Yan","year":"2005","journal-title":"Neuropharmacology"},{"key":"R108-9-20210129","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jmg.2008.063701","article-title":"A pilot open label, single dose trial of fenobam in adults with fragile X syndrome.","volume":"46","author":"Berry-Kravis","year":"2009","journal-title":"J Med Genet"},{"key":"R109-9-20210129","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/DBP.0b013e31817dc447","article-title":"Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome.","volume":"29","author":"Berry-Kravis","year":"2008","journal-title":"J Dev Behav Pediatr"},{"key":"R110-9-20210129","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/cap.2006.16.525","article-title":"Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial.","volume":"16","author":"Berry-Kravis","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R111-9-20210129","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.brainres.2006.08.115","article-title":"Decreased expression of the GABAA receptor in fragile X syndrome.","volume":"1121","author":"D'Hulst","year":"2006","journal-title":"Brain Res"},{"key":"R112-9-20210129","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2004.11.087","article-title":"Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse.","volume":"377","author":"El Idrissi","year":"2005","journal-title":"Neurosci Lett"},{"key":"R113-9-20210129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neulet.2006.11.062","article-title":"Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein.","volume":"412","author":"Selby","year":"2007","journal-title":"Neurosci Lett"},{"key":"R114-9-20210129","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/cercor\/bhn159","article-title":"Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.","volume":"19","author":"Curia","year":"2009","journal-title":"Cereb Cortex"},{"key":"R115-9-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.eplepsyres.2004.09.003","article-title":"Role of neurosteroids in catamenial epilepsy.","volume":"62","author":"Reddy","year":"2004","journal-title":"Epilepsy Res"},{"key":"R116-9-20210129","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/jmg.2008.061796","article-title":"Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.","volume":"46","author":"Bilousova","year":"2009","journal-title":"J Med Genet"},{"key":"R117-9-20210129","doi-asserted-by":"crossref","first-page":"10685","DOI":"10.1523\/JNEUROSCI.2624-07.2007","article-title":"Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome.","volume":"27","author":"Lauterborn","year":"2007","journal-title":"J Neurosci"},{"key":"R118-9-20210129","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/0883073807309786","article-title":"Rett syndrome: recent research progress.","volume":"23","author":"Percy","year":"2008","journal-title":"J Child Neurol"},{"key":"R119-9-20210129","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ana.410140412","article-title":"A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.","volume":"14","author":"Hagberg","year":"1983","journal-title":"Ann Neurol"},{"key":"R120-9-20210129","first-page":"723","article-title":"On a unusual brain atrophy syndrome in hyperammonemia in childhood.","volume":"116","author":"Rett","year":"1966","journal-title":"Wien Med Wochenschr"},{"key":"R121-9-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.2004.027730","article-title":"Rett syndrome: clinical review and genetic update.","volume":"42","author":"Weaving","year":"2005","journal-title":"J Med Genet"},{"key":"R122-9-20210129","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/sj.ejhg.5201580","article-title":"Rett syndrome: new clinical and molecular insights.","volume":"14","author":"Williamson","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"R123-9-20210129","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(92)90610-O","article-title":"Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA.","volume":"69","author":"Lewis","year":"1992","journal-title":"Cell"},{"key":"R124-9-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.","volume":"23","author":"Amir","year":"1999","journal-title":"Nat Genet"},{"key":"R125-9-20210129","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/jmg.2006.042077","article-title":"Very mild cases of Rett syndrome with skewed X inactivation.","volume":"43","author":"Huppke","year":"2006","journal-title":"J Med Genet"},{"issue":"Suppl 1","key":"R126-9-20210129","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S0387-7604(01)00344-8","article-title":"The role of different X-inactivation pattern on the variable clinical phenotype with Rett syndrome.","volume":"23","author":"Ishii","year":"2001","journal-title":"Brain Dev"},{"key":"R127-9-20210129","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1086\/382228","article-title":"X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of Rett syndrome.","volume":"74","author":"Young","year":"2004","journal-title":"Am J Hum Genet"},{"key":"R128-9-20210129","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/08830738050200090501","article-title":"MECP2 abnormality phenotypes: clinicopathologic area with broad variability.","volume":"20","author":"Erlandson","year":"2005","journal-title":"J Child Neurol"},{"key":"R129-9-20210129","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1128\/MCB.18.11.6538","article-title":"Identification and characterization of a family of mammalian methyl-CpG binding proteins.","volume":"18","author":"Hendrich","year":"1998","journal-title":"Mol Cell Biol"},{"key":"R130-9-20210129","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology.","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"R131-9-20210129","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.","volume":"27","author":"Guy","year":"2001","journal-title":"Nat Genet"},{"key":"R132-9-20210129","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(02)00768-7","article-title":"Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3.","volume":"35","author":"Shahbazian","year":"2002","journal-title":"Neuron"},{"key":"R133-9-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2007.08.039","article-title":"Ube3a mRNA and protein expression are not decreased in Mecp2R168X mutant mice.","volume":"1180","author":"Lawson-Yuen","year":"2007","journal-title":"Brain Res"},{"key":"R134-9-20210129","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/85906","article-title":"Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.","volume":"27","author":"Chen","year":"2001","journal-title":"Nat Genet"},{"key":"R135-9-20210129","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/brain\/awl022","article-title":"Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice.","volume":"129","author":"Pelka","year":"2006","journal-title":"Brain"},{"key":"R136-9-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/hmg\/ddi016","article-title":"Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome.","volume":"14","author":"Moretti","year":"2005","journal-title":"Hum Mol Genet"},{"key":"R137-9-20210129","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.cub.2006.02.062","article-title":"MeCP2-dependent transcriptional repression regulates excitatory neurotransmission.","volume":"16","author":"Nelson","year":"2006","journal-title":"Curr Biol"},{"key":"R138-9-20210129","doi-asserted-by":"crossref","first-page":"12560","DOI":"10.1073\/pnas.0506071102","article-title":"Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome.","volume":"102","author":"Dani","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R139-9-20210129","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1152\/jn.00826.2007","article-title":"Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome.","volume":"99","author":"Medrihan","year":"2008","journal-title":"J Neurophysiol"},{"key":"R140-9-20210129","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuron.2007.08.018","article-title":"MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number.","volume":"56","author":"Chao","year":"2007","journal-title":"Neuron"},{"key":"R141-9-20210129","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.1086446","article-title":"Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2.","volume":"302","author":"Chen","year":"2003","journal-title":"Science"},{"key":"R142-9-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.nbd.2005.07.005","article-title":"Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome.","volume":"21","author":"Asaka","year":"2006","journal-title":"Neurobiol Dis"},{"key":"R143-9-20210129","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1523\/JNEUROSCI.2623-05.2006","article-title":"Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome.","volume":"26","author":"Moretti","year":"2006","journal-title":"J Neurosci"},{"key":"R144-9-20210129","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/hmg\/ddh282","article-title":"Mild overexpression of MeCP2 causes a progressive neurological disorder in mice.","volume":"13","author":"Collins","year":"2004","journal-title":"Hum Mol Genet"},{"key":"R145-9-20210129","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/hmg\/ddn026","article-title":"Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice.","volume":"17","author":"Jugloff","year":"2008","journal-title":"Hum Mol Genet"},{"key":"R146-9-20210129","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1073\/pnas.0401626101","article-title":"Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice.","volume":"101","author":"Luikenhuis","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R147-9-20210129","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/hmg\/ddm185","article-title":"Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.","volume":"16","author":"Alvarez-Saavedra","year":"2007","journal-title":"Hum Mol Genet"},{"key":"R148-9-20210129","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.0610593104","article-title":"Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.","volume":"104","author":"Giacometti","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R149-9-20210129","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome.","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"R150-9-20210129","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice.","volume":"106","author":"Tropea","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R151-9-20210129","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/09638280150504207","article-title":"Behavioural and emotional features in Rett syndrome.","volume":"23","author":"Mount","year":"2001","journal-title":"Disabil Rehabil"},{"key":"R152-9-20210129","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/hmg\/ddi229","article-title":"Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome.","volume":"14","author":"Nuber","year":"2005","journal-title":"Hum Mol Genet"},{"key":"R153-9-20210129","doi-asserted-by":"crossref","first-page":"18267","DOI":"10.1073\/pnas.0608702103","article-title":"Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome.","volume":"103","author":"McGill","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R154-9-20210129","doi-asserted-by":"crossref","first-page":"21966","DOI":"10.1073\/pnas.0912257106","article-title":"Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities.","volume":"106","author":"Samaco","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R155-9-20210129","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1523\/JNEUROSCI.4373-05.2005","article-title":"Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice.","volume":"25","author":"Viemari","year":"2005","journal-title":"J Neurosci"},{"key":"R156-9-20210129","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/j.1460-9568.2007.05466.x","article-title":"Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome.","volume":"25","author":"Roux","year":"2007","journal-title":"Eur J Neurosci"},{"key":"R157-9-20210129","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.resp.2007.08.009","article-title":"Oral treatment with desipramine improves breathing and life span in Rett syndrome mouse model.","volume":"160","author":"Zanella","year":"2008","journal-title":"Respir Physiol Neurobiol"},{"key":"R158-9-20210129","doi-asserted-by":"crossref","first-page":"10912","DOI":"10.1523\/JNEUROSCI.1869-07.2007","article-title":"Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome.","volume":"27","author":"Ogier","year":"2007","journal-title":"J Neurosci"},{"key":"R159-9-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8","article-title":"Epidemiology of neurofibromatosis type 1.","volume":"89","author":"Friedman","year":"1999","journal-title":"Am J Med Genet"},{"key":"R160-9-20210129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients.","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"key":"R161-9-20210129","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s004390050746","article-title":"Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay.","volume":"102","author":"Upadhyaya","year":"1998","journal-title":"Hum Genet"},{"key":"R162-9-20210129","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.spen.2006.01.005","article-title":"Clinical manifestations and management of neurofibromatosis type 1.","volume":"13","author":"Tonsgard","year":"2006","journal-title":"Semin Pediatr Neurol"},{"key":"R163-9-20210129","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1212\/01.wnl.0000179303.72345.ce","article-title":"The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.","volume":"65","author":"Hyman","year":"2005","journal-title":"Neurology"},{"key":"R164-9-20210129","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/WNL.48.4.1121","article-title":"Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force.","volume":"48","author":"North","year":"1997","journal-title":"Neurology"},{"key":"R165-9-20210129","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0896-6273(92)90270-N","article-title":"The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes.","volume":"8","author":"Daston","year":"1992","journal-title":"Neuron"},{"key":"R166-9-20210129","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1523-1747.ep12379925","article-title":"Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin.","volume":"102","author":"Malhotra","year":"1994","journal-title":"J Invest Dermatol"},{"key":"R167-9-20210129","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","article-title":"The neurofibromatosis type 1 gene encodes a protein related to GAP.","volume":"62","author":"Xu","year":"1990","journal-title":"Cell"},{"key":"R168-9-20210129","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1126\/science.286.5447.2172","article-title":"Mouse models of tumor development in neurofibromatosis type 1.","volume":"286","author":"Cichowski","year":"1999","journal-title":"Science"},{"key":"R169-9-20210129","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1126\/science.276.5313.795","article-title":"Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides.","volume":"276","author":"Guo","year":"1997","journal-title":"Science"},{"key":"R170-9-20210129","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1126\/science.276.5313.791","article-title":"Rescue of a Drosophila NF1 mutant phenotype by protein kinase A.","volume":"276","author":"The","year":"1997","journal-title":"Science"},{"key":"R171-9-20210129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nn792","article-title":"Neurofibromin regulates G protein-stimulated adenylyl cyclase activity.","volume":"5","author":"Tong","year":"2002","journal-title":"Nat Neurosci"},{"key":"R172-9-20210129","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/35002593","article-title":"A neurofibromatosis-1-regulated pathway is required for learning in Drosophila.","volume":"403","author":"Guo","year":"2000","journal-title":"Nature"},{"key":"R173-9-20210129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/ng0397-281","article-title":"A mouse model for the learning and memory deficits associated with neurofibromatosis type I.","volume":"15","author":"Silva","year":"1997","journal-title":"Nat Genet"},{"key":"R174-9-20210129","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0006-8993(98)01133-0","article-title":"Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor.","volume":"816","author":"Rizvi","year":"1999","journal-title":"Brain Res"},{"key":"R175-9-20210129","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.862101","article-title":"Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.","volume":"15","author":"Zhu","year":"2001","journal-title":"Genes Dev"},{"key":"R176-9-20210129","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/86898","article-title":"Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1.","volume":"27","author":"Costa","year":"2001","journal-title":"Nat Genet"},{"key":"R177-9-20210129","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature711","article-title":"Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1.","volume":"415","author":"Costa","year":"2002","journal-title":"Nature"},{"key":"R178-9-20210129","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2008.09.060","article-title":"Neurofibromin regulation of ERK signaling modulates GABA release and learning.","volume":"135","author":"Cui","year":"2008","journal-title":"Cell"},{"key":"R179-9-20210129","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cub.2005.09.043","article-title":"The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1.","volume":"15","author":"Li","year":"2005","journal-title":"Curr Biol"},{"key":"R180-9-20210129","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.300.3.287","article-title":"Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.","volume":"300","author":"Krab","year":"2008","journal-title":"JAMA"},{"key":"R181-9-20210129","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR.","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R182-9-20210129","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"R183-9-20210129","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16.","volume":"75","year":"1993","journal-title":"Cell"},{"key":"R184-9-20210129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis.","volume":"615","author":"Osborne","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"R185-9-20210129","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00431-001-0903-7","article-title":"TSC1 and TSC2 mutations in tuberous sclerosis, the associated phenotypes and a model to explain observed TSC1\/TSC2 frequency ratios.","volume":"161","author":"Langkau","year":"2002","journal-title":"Eur J Pediatr"},{"key":"R186-9-20210129","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1469-8749.1996.tb12086.x","article-title":"Morbidity associated with tuberous sclerosis: a population study.","volume":"38","author":"Webb","year":"1996","journal-title":"Dev Med Child Neurol"},{"key":"R187-9-20210129","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/WCO.0b013e3280895d93","article-title":"Neuroimaging in tuberous sclerosis complex.","volume":"20","author":"Luat","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"R188-9-20210129","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/(SICI)1096-8628(19991215)88:6<642::AID-AJMG12>3.0.CO;2-O","article-title":"Cognitive deficits in normally intelligent patients with tuberous sclerosis.","volume":"88","author":"Harrison","year":"1999","journal-title":"Am J Med Genet"},{"key":"R189-9-20210129","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1177\/08830738040190090601","article-title":"Behavioral and cognitive aspects of tuberous sclerosis complex.","volume":"19","author":"Prather","year":"2004","journal-title":"J Child Neurol"},{"key":"R190-9-20210129","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1469-8749.1994.tb11765.x","article-title":"Autistic behaviour and attention deficits in tuberous sclerosis: a population-based study.","volume":"36","author":"Gillberg","year":"1994","journal-title":"Dev Med Child Neurol"},{"key":"R191-9-20210129","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1017\/S0033291702007092","article-title":"Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex.","volume":"33","author":"Joinson","year":"2003","journal-title":"Psychol Med"},{"key":"R192-9-20210129","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awf124","article-title":"Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex.","volume":"125","author":"Bolton","year":"2002","journal-title":"Brain"},{"key":"R193-9-20210129","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0387-7604(01)00300-X","article-title":"Infantile spasms in tuberous sclerosis complex.","volume":"23","author":"Curatolo","year":"2001","journal-title":"Brain Dev"},{"key":"R194-9-20210129","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2788.2009.01208.x","article-title":"From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis.","volume":"53","author":"Ehninger","year":"2009","journal-title":"J Intellect Disabil Res"},{"key":"R195-9-20210129","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mrrev.2008.01.001","article-title":"The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners.","volume":"658","author":"Rosner","year":"2008","journal-title":"Mutat Res"},{"issue":"Spec No. 2","key":"R196-9-20210129","doi-asserted-by":"crossref","first-page":"R251","DOI":"10.1093\/hmg\/ddi260","article-title":"Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.","volume":"14","author":"Kwiatkowski","year":"2005","journal-title":"Hum Mol Genet"},{"key":"R197-9-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1385\/MN:34:3:205","article-title":"The growing role of mTOR in neuronal development and plasticity.","volume":"34","author":"Jaworski","year":"2006","journal-title":"Mol Neurobiol"},{"key":"R198-9-20210129","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.","volume":"99","author":"Tee","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R199-9-20210129","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","article-title":"Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.","volume":"13","author":"Tee","year":"2003","journal-title":"Curr Biol"},{"key":"R200-9-20210129","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0092-8674(00)80657-1","article-title":"gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle.","volume":"96","author":"Ito","year":"1999","journal-title":"Cell"},{"key":"R201-9-20210129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0092-8674(01)00332-4","article-title":"The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation.","volume":"105","author":"Tapon","year":"2001","journal-title":"Cell"},{"key":"R202-9-20210129","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1101\/gad.901101","article-title":"TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth.","volume":"15","author":"Gao","year":"2001","journal-title":"Genes Dev"},{"key":"R203-9-20210129","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of tuberous sclerosis.","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat Med"},{"key":"R204-9-20210129","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1523\/JNEUROSCI.5540-06.2007","article-title":"A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival.","volume":"27","author":"Meikle","year":"2007","journal-title":"J Neurosci"},{"key":"R205-9-20210129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.10283","article-title":"Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures.","volume":"52","author":"Uhlmann","year":"2002","journal-title":"Ann Neurol"},{"key":"R206-9-20210129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.21058","article-title":"Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1.","volume":"61","author":"Wang","year":"2007","journal-title":"Ann Neurol"},{"key":"R207-9-20210129","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nbd.2007.07.015","article-title":"Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex.","volume":"28","author":"Zeng","year":"2007","journal-title":"Neurobiol Dis"},{"key":"R208-9-20210129","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.21317","article-title":"Cognitive deficits in Tsc1+\/\u2212 mice in the absence of cerebral lesions and seizures.","volume":"62","author":"Goorden","year":"2007","journal-title":"Ann Neurol"},{"key":"R209-9-20210129","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1460-9568.2006.04594.x","article-title":"Impaired synaptic plasticity in a rat model of tuberous sclerosis.","volume":"23","author":"von der Brelie","year":"2006","journal-title":"Eur J Neurosci"},{"key":"R210-9-20210129","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1471-4159.2005.03538.x","article-title":"Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis.","volume":"96","author":"Waltereit","year":"2006","journal-title":"J Neurochem"},{"key":"R211-9-20210129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/088307389901400201","article-title":"Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review.","volume":"14","author":"Hancock","year":"1999","journal-title":"J Child Neurol"},{"key":"R212-9-20210129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0920-1211(99)00082-0","article-title":"Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.","volume":"38","author":"Jambaqu\u00e9","year":"2000","journal-title":"Epilepsy Res"},{"key":"R213-9-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/08830738060210011201","article-title":"Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial.","volume":"21","author":"Collins","year":"2006","journal-title":"J Child Neurol"},{"key":"R214-9-20210129","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/med.20049","article-title":"Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment.","volume":"26","author":"Jozwiak","year":"2006","journal-title":"Med Res Rev"},{"key":"R215-9-20210129","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann Neurol"},{"key":"R216-9-20210129","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function.","volume":"28","author":"Meikle","year":"2008","journal-title":"J Neurosci"},{"key":"R217-9-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-5945-8-1","article-title":"Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model.","volume":"8","author":"Rauktys","year":"2008","journal-title":"BMC Dermatol"},{"key":"R218-9-20210129","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1203\/01.PDR.0000147727.78571.07","article-title":"Effects of rapamycin in the Eker rat model of tuberous sclerosis complex.","volume":"57","author":"Kenerson","year":"2005","journal-title":"Pediatr Res"},{"key":"R219-9-20210129","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2210-7-14","article-title":"Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779.","volume":"7","author":"Messina","year":"2007","journal-title":"BMC Pharmacol"},{"key":"R220-9-20210129","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/gcc.20357","article-title":"Combination of a rapamycin analog (CCI-779) and interferon-gamma is more effective than single agents in treating a mouse model of tuberous sclerosis complex.","volume":"45","author":"Lee","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"R221-9-20210129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.","volume":"68","author":"Dabora","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R222-9-20210129","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/mrdd.20020","article-title":"Brain development in autism: early overgrowth followed by premature arrest of growth.","volume":"10","author":"Courchesne","year":"2004","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"R223-9-20210129","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tins.2007.12.005","article-title":"Neuroanatomy of autism.","volume":"31","author":"Amaral","year":"2008","journal-title":"Trends Neurosci"},{"key":"R224-9-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.conb.2005.03.001","article-title":"Why the frontal cortex in autism might be talking only to itself: local over-connectivity but long-distance disconnection.","volume":"15","author":"Courchesne","year":"2005","journal-title":"Curr Opin Neurobiol"},{"key":"R225-9-20210129","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1203\/PDR.0b013e31819e7203","article-title":"Epidemiology of pervasive developmental disorders.","volume":"65","author":"Fombonne","year":"2009","journal-title":"Pediatr Res"},{"key":"R226-9-20210129","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11910-009-0029-2","article-title":"Genetics of autism spectrum disorders.","volume":"9","author":"Kumar","year":"2009","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R227-9-20210129","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/35103559","article-title":"Genetics of autism: complex aetiology for a heterogeneous disorder.","volume":"2","author":"Folstein","year":"2001","journal-title":"Nat Rev Genet"},{"key":"R228-9-20210129","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ng1985","article-title":"Mapping autism risk loci using genetic linkage and chromosomal rearrangements.","volume":"39","author":"Szatmari","year":"2007","journal-title":"Nat Genet"},{"key":"R229-9-20210129","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tins.2006.05.010","article-title":"Searching for ways out of the autism maze: genetic, epigenetic and environmental clues.","volume":"29","author":"Persico","year":"2006","journal-title":"Trends Neurosci"},{"key":"R230-9-20210129","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mrdd.20044","article-title":"Toward a developmental neurobiology of autism.","volume":"10","author":"Polleux","year":"2004","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"R231-9-20210129","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WCO.0b013e328336a01f","article-title":"Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders.","volume":"23","author":"Herbert","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"R232-9-20210129","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/MOP.0b013e328336eb9a","article-title":"What causes autism? Exploring the environmental contribution.","volume":"22","author":"Landrigan","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"R233-9-20210129","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.mp.4001896","article-title":"The genetics of autistic disorders and its clinical relevance: a review of the literature.","volume":"12","author":"Freitag","year":"2007","journal-title":"Mol Psychiatry"},{"key":"R234-9-20210129","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1750-3639.2007.00102.x","article-title":"The neurobiology of autism.","volume":"17","author":"Pardo","year":"2007","journal-title":"Brain Pathol"},{"key":"R235-9-20210129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.conb.2009.06.003","article-title":"A synaptic trek to autism.","volume":"19","author":"Bourgeron","year":"2009","journal-title":"Curr Opin Neurobiol"},{"key":"R236-9-20210129","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ridd.2005.03.003","article-title":"Neurochemical correlates of autistic disorder: a review of the literature.","volume":"27","author":"Lam","year":"2006","journal-title":"Res Dev Disabil"},{"key":"R237-9-20210129","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/sj.mp.4002082","article-title":"Advances in behavioral genetics: mouse models of autism.","volume":"13","author":"Moy","year":"2008","journal-title":"Mol Psychiatry"},{"key":"R238-9-20210129","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/nn1765","article-title":"Fragile X syndrome and autism at the intersection of genetic and neural networks.","volume":"9","author":"Belmonte","year":"2006","journal-title":"Nat Neurosci"},{"key":"R239-9-20210129","doi-asserted-by":"crossref","first-page":"22365","DOI":"10.1074\/jbc.M410723200","article-title":"Dissection of synapse induction by neuroligins: effect of a neuroligin mutation associated with autism.","volume":"280","author":"Chubykin","year":"2005","journal-title":"J Biol Chem"},{"key":"R240-9-20210129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tins.2005.11.003","article-title":"Neuroligins and neurexins: linking cell adhesion, synapse formation and cognitive function.","volume":"29","author":"Dean","year":"2006","journal-title":"Trends Neurosci"},{"key":"R241-9-20210129","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nature07456","article-title":"Neuroligins and neurexins link synaptic function to cognitive disease.","volume":"455","author":"S\u00fcdhof","year":"2008","journal-title":"Nature"},{"key":"R242-9-20210129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng1136","article-title":"Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.","volume":"34","author":"Jamain","year":"2003","journal-title":"Nat Genet"},{"key":"R243-9-20210129","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1086\/382137","article-title":"X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family.","volume":"74","author":"Laumonnier","year":"2004","journal-title":"Am J Hum Genet"},{"key":"R244-9-20210129","doi-asserted-by":"crossref","first-page":"10843","DOI":"10.1523\/JNEUROSCI.1248-09.2009","article-title":"A neuroligin-4 missense mutation associated with autism impairs neuroligin-4 folding and endoplasmic reticulum export.","volume":"29","author":"Zhang","year":"2009","journal-title":"J Neurosci"},{"key":"R245-9-20210129","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1073\/pnas.96.3.1100","article-title":"Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses.","volume":"96","author":"Song","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R246-9-20210129","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1078\/0171-9335-00410","article-title":"Neuroligin 2 is exclusively localized to inhibitory synapses.","volume":"83","author":"Varoqueaux","year":"2004","journal-title":"Eur J Cell Biol"},{"key":"R247-9-20210129","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1126\/science.1107470","article-title":"Control of excitatory and inhibitory synapse formation by neuroligins.","volume":"307","author":"Chih","year":"2005","journal-title":"Science"},{"key":"R248-9-20210129","doi-asserted-by":"crossref","first-page":"13915","DOI":"10.1073\/pnas.0405939101","article-title":"A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin.","volume":"101","author":"Prange","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R249-9-20210129","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.neuron.2007.05.029","article-title":"Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2.","volume":"54","author":"Chubykin","year":"2007","journal-title":"Neuron"},{"key":"R250-9-20210129","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1523\/JNEUROSCI.0032-08.2008","article-title":"Synaptic imbalance, stereotypies, and impaired social interactions in mice with altered neuroligin 2 expression.","volume":"28","author":"Hines","year":"2008","journal-title":"J Neurosci"},{"key":"R251-9-20210129","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1523\/JNEUROSCI.4517-09.2010","article-title":"Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior.","volume":"30","author":"Blundell","year":"2010","journal-title":"J Neurosci"},{"key":"R252-9-20210129","doi-asserted-by":"crossref","first-page":"9087","DOI":"10.1073\/pnas.0803448105","article-title":"Neuroligin-1 is required for normal expression of LTP and associative fear memory in the amygdala of adult animals.","volume":"105","author":"Kim","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R253-9-20210129","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1601-183X.2009.00487.x","article-title":"Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit.","volume":"8","author":"Radyushkin","year":"2009","journal-title":"Genes Brain Behav"},{"key":"R254-9-20210129","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1471-4159.2002.00931.x","article-title":"ProSAP\/Shank proteins\u2014a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease.","volume":"81","author":"Boeckers","year":"2002","journal-title":"J Neurochem"},{"key":"R255-9-20210129","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng1933","article-title":"Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.","volume":"39","author":"Durand","year":"2007","journal-title":"Nat Genet"},{"key":"R256-9-20210129","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ajmg.b.30822","article-title":"Novel de novo SHANK3 mutation in autistic patients.","volume":"150B","author":"Gauthier","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R257-9-20210129","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/522590","article-title":"Contribution of SHANK3 mutations to autism spectrum disorder.","volume":"81","author":"Moessner","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R258-9-20210129","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1523\/JNEUROSCI.3032-07.2008","article-title":"Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1.","volume":"28","author":"Hung","year":"2008","journal-title":"J Neurosci"},{"key":"R259-9-20210129","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajhg.2007.09.005","article-title":"Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene.","volume":"82","author":"Alarc\u00f3n","year":"2008","journal-title":"Am J Hum Genet"},{"key":"R260-9-20210129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1098\/rstb.2008.0143","article-title":"Enhanced activity of human serotonin transporter variants associated with autism.","volume":"364","author":"Prasad","year":"2009","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R261-9-20210129","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/432648","article-title":"Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors.","volume":"77","author":"Sutcliffe","year":"2005","journal-title":"Am J Hum Genet"},{"key":"R262-9-20210129","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ajmg.b.20151","article-title":"Linkage and association analysis at the serotonin transporter (SLC6A4) locus in a rigid-compulsive subset of autism.","volume":"127B","author":"McCauley","year":"2004","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R263-9-20210129","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3476(61)80261-8","article-title":"Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children.","volume":"58","author":"Schain","year":"1961","journal-title":"J Pediatr"},{"key":"R264-9-20210129","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1101\/sqb.2007.72.020","article-title":"The possible interplay of synaptic and clock genes in autism spectrum disorders.","volume":"72","author":"Bourgeron","year":"2007","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"R265-9-20210129","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archgenpsychiatry.2009.30","article-title":"Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.","volume":"66","author":"King","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"R266-9-20210129","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.chc.2005.08.005","article-title":"An update on pharmacologic treatments for autism spectrum disorders.","volume":"15","author":"King","year":"2006","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"R267-9-20210129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10673220802075852","article-title":"Pharmacological treatment options for autism spectrum disorders in children and adolescents.","volume":"16","author":"Leskovec","year":"2008","journal-title":"Harv Rev Psychiatry"},{"key":"R268-9-20210129","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1176\/appi.ajp.162.7.1361","article-title":"Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.","volume":"162","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R269-9-20210129","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/CHI.0b013e3181b76658","article-title":"A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.","volume":"48","author":"Marcus","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R270-9-20210129","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/jmg.2008.064667","article-title":"Fragile X syndrome: from molecular genetics to therapy.","volume":"46","author":"D'Hulst","year":"2009","journal-title":"J Med Genet"},{"key":"R271-9-20210129","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/FBP.0b013e32830c3645","article-title":"Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches.","volume":"19","author":"Ricceri","year":"2008","journal-title":"Behav Pharmacol"},{"key":"R272-9-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1059-1311(05)80079-2","article-title":"Epilepsy and associated effects on adaptive behaviour in adults with Down syndrome.","volume":"4","author":"Prasher","year":"1995","journal-title":"Seizure"},{"key":"R273-9-20210129","first-page":"49","article-title":"Neuropsychiatric aspects of hypothyroidism and treatment reversibility.","volume":"32","author":"Davis","year":"2007","journal-title":"Minerva Endocrinol"},{"key":"R274-9-20210129","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis.","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"R275-9-20210129","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/WCO.0b013e32832c4ff5","article-title":"Tuberous sclerosis complex: a brave new world?","volume":"23","author":"Ess","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"R276-9-20210129","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbagen.2009.02.007","article-title":"FMR1: a gene with three faces.","volume":"1790","author":"Oostra","year":"2009","journal-title":"Biochim Biophys Acta"}],"container-title":["Journal of Developmental &amp; Behavioral Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004703-201009000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:40:19Z","timestamp":1786041619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004703-201009000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":275,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/dbp.0b013e3181ee3833","relation":{},"ISSN":["0196-206X"],"issn-type":[{"value":"0196-206X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}